You are here: Industry Insights > Pfizer

News List

Sosei Heptares scores $5m milestone payment from Pfizer pharmatimes
October 09, 2020
Sosei Heptares has received a $5m milestone payment from its strategic alliance partner Pfizer after the first subject in a clinical trial was dosed with a new drug candidate from the collaboration between the two companies.
OnKure, Pfizer collaborate to evaluate combination of OKI-179 and binimetinib pharmaceutical-business-review
September 27, 2020
OnKure, a leader in discovery and development of next generation histone deacetylase (HDAC) inhibitors, entered into a clinical trial collaboration and supply agreement with Pfizer to support the clinical proof of concept study for MEKTOVI (binimetinib)..
FDA grants priority review for Pfizer’s Xalkori in paediatric ALCL pharmaceutical-technology
September 27, 2020
Pfizer has secured priority review from the US Food and Drug Administration (FDA) for Xalkori (crizotinib) to treat relapsed or refractory systemic anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma (ALCL) in children.
Pfizer and BioNTech submit proposal to US FDA to expand COVID-19 vaccine trial expresspharma
September 24, 2020
The companies expect that a conclusive readout on efficacy is likely by the end of October.
Vivet, Pfizer sign manufacturing pact for investigational gene therapy to treat Wilson disease expresspharma
September 24, 2020
Vivet Therapeutics and Pfizer announced that they have entered into a manufacturing agreement, under which Pfizer will provide clinical supply for a Phase 1/2 clinical trial evaluating Vivet’s proprietary, investigational gene therapy, VTX-801 ...
Pfizer, BioNTech could supply EU with 300m doses of SARS-CoV-2 vaccine pharmatimes
September 24, 2020
Pfizer and BioNTech have concluded exploratory talks with the European Commission for a proposed supply of 200 million doses of their investigational BNT162 mRNA-based vaccine candidate against SARS-CoV-2 to EU nations ...
Pfizer, BioNTech Inch Closer to COVID-19 Vax Deal with EU contractpharma
September 24, 2020
Could supply the EU with 200 million doses of mRNA-based vaccine candidate against SARS-CoV-2.
Pfizer and BioNTech to potentially supply EU with 200 mn doses of COVID-19 vaccine candidate expresspharma
September 23, 2020
The proposed agreement also has an option to purchase additional 100 million doses, with deliveries starting by the end of 2020, subject to regulatory approval.
Mylan, Pfizer Receive EC Approval for Proposed Combination of Mylan and Upjohn americanpharmaceuticalreview
September 22, 2020
Mylan and Pfizer announced the companies have received final approval from the European Commission (EC) for the proposed combination of Mylan and Pfizer's Upjohn business.
EC concludes talks with Pfizer, BioNTech for Covid-19 vaccine supply pharmaceutical-technology
September 18, 2020
The European Commission (EC) has concluded exploratory talks with Pfizer and BioNTech for the potential supply of 200 million doses of the companies’ BNT162 mRNA-based Covid-19 vaccine candidate to the European Union (EU) Member States.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 83 84 Next page